The quality management of Alacris Theranostics GmbH has been certified by TÜV Süd according to ISO 9001:2015. Alacris therefore fulfills the requirements for a quality management system according to the latest revision of ISO 9001.
Alacris focuses on personalized medicine and requires its own state-of-the-art next-generation sequencing lab with an efficient sequencing and data analysis pipeline. Building on this infrastructure, Alacris is developing new approaches to biomarker identification and personalized tumor characterization.
“The successful certification confirms our self-understanding as a constantly evolving company, with a pronounced focus on our customers and the quality of our services,” explains Dr. Bodo Lange, CEO of Alacris Theranostics GmbH. “Our analyzes in the field of personalized medicine and preclinical (research) projects are inconceivable without a comprehensive quality management system.”